Abolfazl Miri: Improving ITP Diagnosis with Readily Available Hematological Indices
Abolfazl Miri, Laboratory Hematology and Transfusion Medicine Specialist at Shahid Beheshti University of Medical Sciences, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Sage Journals, adding:
“Can routine CBC parameters help improve ITP diagnosis?
Our recent study investigated NLR, PLR, and HPR in patients with Immune Thrombocytopenic Purpura (ITP).
The most interesting finding was the excellent diagnostic performance of PLR and HPR, suggesting that inexpensive and readily available hematological indices may support clinical decision-making in ITP.
Sometimes valuable biomarkers are already present in the tests we perform every day.
What is your experience with inflammatory indices in autoimmune hematologic disorders?”
Title: Evaluation of Hemato-Inflammatory Parameters NLR, PLR and HPR in Patients with Immune Thrombocytopenic Purpura (ITP) in South-East Iran: A Retrospective Study
Authors: Mobina Nakhaei Shamahmood, Kiyana Tavakoli, Behzad Rafat, Abolfazl Miri, Mohammad Hossein Ahmadi, Younes Sadeghi-Bojd
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 28, 2026, 05:17Burcu Tunakan: Turning Collaboration into Better Outcomes for People with Hemophilia
-
Jun 28, 2026, 05:08Kathrine Kaspersen: The Power of Voluntary Plasma Donation
-
Jun 28, 2026, 04:55Sana Helani: Challenging Common Assumptions in Anemia Management
-
Jun 28, 2026, 04:55Samwel Mikaye: The Collapse of Coagulation Control in Disseminated Intravascular Coagulation
-
Jun 28, 2026, 04:22Jensa Morris: Why Low Molecular Weight Heparins Should Be the First Choice for VTE
-
Jun 28, 2026, 03:57Sara Zalghout: Navigating the Often-Unspoken Challenges of Academia at ISTH 2026
-
Jun 28, 2026, 02:56Carlo Alfieri: Redefining Anemia Management After Kidney Transplantation
-
Jun 28, 2026, 02:36Ramesh Chennupat: Anemia is Associated with Increased REV Release in Stable Coronary Artery Disease
-
Jun 28, 2026, 02:01RishiRaj Sinha: Driving the Future of Transfusion Medicine Through Global Collaboration at ISBT 2026